3M’s NYSE: MMM rebound is gaining momentum because of surprisingly good results. Today’s story is that repositioning efforts are taking hold and driving improved profitability while litigation risks dwindle. The takeaways from the Q2 report include better-than-expected top and bottom-line results, organic sequential growth in all segments, improved margin, and increased guidance that affirms the … Read more
Some names in the retail and apparel sectors have made a splash in investors’ monitors in recent weeks, even months. Unfortunately, the attention is founded on seriously bearish price action, like the fact that shares of Lululemon Athletica Inc. NASDAQ: LULU are now trading at only 48% of their 52-week high, which is dangerously close … Read more
As earnings season unfolds and several mega-cap tech stocks, including members of the “Magnificent Seven,” have reported, the overall market and tech sector have seen significant declines in recent weeks. The XLK technology sector ETF has dropped nearly 6% this month and is now down over 10% from its recent 52-week highs. Similarly, the broader … Read more
$827.85 -0.94 (-0.11%) (As of 07/26/2024 ET) 52-Week Range $527.24 ▼ $850.33 P/E Ratio 88.54 Price Target $833.57 ServiceNow Inc. NYSE: NOW, a leading provider of cloud-based software solutions, has recently made headlines with a notable 15% surge in its stock price following a strong earnings report. This impressive gain brings its year-to-date performance to nearly … Read more
MOH Molina Healthcare $335.36 +11.19 (+3.45%) (As of 07/26/2024 ET) 52-Week Range $282.96 ▼ $423.92 P/E Ratio 18.20 Price Target $376.18 Molina Healthcare, Inc. NYSE: MOH is a leading provider of managed healthcare services, primarily focusing on government-sponsored programs such as Medicaid and Medicare. Molina Healthcare’s earnings report for the second quarter was released, and it … Read more
$78.13 -0.39 (-0.50%) (As of 07/26/2024 ET) 52-Week Range $60.47 ▼ $80.86 Dividend Yield 2.47% P/E Ratio 38.30 Price Target $88.00 AstraZeneca PLC NASDAQ: AZN is a United Kingdom-based healthcare firm and the sixth-largest pharmaceutical company in the world by market capitalization. So far, in 2024, the firm has outperformed the market and its sector, achieving a total return … Read more
VKTX Viking Therapeutics $65.98 +1.30 (+2.01%) (As of 07/26/2024 ET) 52-Week Range $8.28 ▼ $99.41 Price Target $111.78 Viking Therapeutics NASDAQ: VKTX is a clinical-stage biopharmaceutical company known for its focus on developing novel treatments for metabolic and endocrine disorders. Viking Therapeutics’ earnings report for the second quarter of 2024 was impressive, capturing the attention of … Read more
Investors who remained heavily invested in the technology sector should start watching the broader market’s behavior today, as names in artificial intelligence like NVIDIA Co. NASDAQ: NVDA are potentially coming out of favor. A rotation into other areas and asset classes has started in the past couple of weeks, and riding the momentum could prove … Read more
Since closing at a record high less than 10 days ago, the benchmark S&P 500 index has been on the back foot. For the moment, it’s not looking like a whole lot more than a healthy mid-rally correction. After all, it had logged almost 40% of gains this year so far, and some questions were … Read more
$180.05 +4.66 (+2.66%) (As of 07/26/2024 ET) 52-Week Range $104.33 ▼ $230.63 Dividend Yield 1.89% P/E Ratio 24.20 Price Target $199.63 Equities across the board are starting to soften after months of gains, making it a good time to go bargain-hunting. Many of the stocks that have enjoyed triple-digit percentage gains this past year are also … Read more